The rapidly changing legal landscape facing the medical device industry demands creative individuals who can provide knowledgeable and skilled counsel and advice to medical device manufacturers and bioscience research laboratories. Whether it is the creation of a new biomedically engineered product or an improvement on an existing medical device, our intellectual property law professionals have rigorously guided our clients through the process of procuring and protecting their intellectual property rights.
HULSEYIP intellectual property law practitioners have experience with a broad range of biomechanical technologies, bioengineered products, biomedical manufacturing processes, dental products, diagnostic technologies, drug-device combination products, electronic medical records information technologies, medical devices, medical image processing software, and medical instrumentation. We are passionately focused on securing and protecting your medical innovation.
Our intellectual property law practitioners ensure that all patent claims abide by the existing guidelines regulating the manufacturing, distribution, and sale of products as covered by the U.S. Food & Drug Administration (FDA) under the 1976 Medical Devices Amendment and 1990 Safe Medical Devices Act. Because the medical device industry is so highly regulated, HULSEYIP continuously monitors the industry for any new government regulations or guidelines that could affect our clients.
Our Medical Devices, Bioengineering, & Biomechanical Technologies practice assists clients, clinicians, manufacturers, and researchers, with:
Protecting, commercializing, and enforcing IP rights
Providing legal review and input early in the product development process
Analyzing the patents of others
Meeting complex regulatory requirements
Obtaining FDA marketing authorization
Developing a licensing strategy
Conducting document review and analysis of data
Counseling on how to attain quality assurance
Providing review of abstracts and manuscripts
Analyzing the copyright implications of new biomedical businesses
Developing a trademark strategy
|
